Tetsuya Aiba

699 total citations
51 papers, 606 citations indexed

About

Tetsuya Aiba is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Tetsuya Aiba has authored 51 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Molecular Biology and 16 papers in Pharmacology. Recurrent topics in Tetsuya Aiba's work include Drug Transport and Resistance Mechanisms (16 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Ion Transport and Channel Regulation (6 papers). Tetsuya Aiba is often cited by papers focused on Drug Transport and Resistance Mechanisms (16 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Ion Transport and Channel Regulation (6 papers). Tetsuya Aiba collaborates with scholars based in Japan, United Kingdom and United States. Tetsuya Aiba's co-authors include Yuji Kurosaki, Yukiya Hashimoto, TAMOTSU KOIZUMI, Kazunori Katayama, Tomomi Hatanaka, Hiromu Kawasaki, Mariko Yoshinaga, Kazuya Ishida, Yoshihiro Saito and Ryohei Hori and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Tetsuya Aiba

49 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuya Aiba Japan 16 166 139 121 106 96 51 606
Dale K. Yu United States 12 148 0.9× 95 0.7× 106 0.9× 32 0.3× 59 0.6× 24 436
Keith E. Anderson Canada 9 98 0.6× 129 0.9× 47 0.4× 201 1.9× 152 1.6× 18 807
Elena Suárez Spain 14 118 0.7× 98 0.7× 148 1.2× 18 0.2× 98 1.0× 59 659
M Ronchi Italy 15 195 1.2× 53 0.4× 87 0.7× 24 0.2× 139 1.4× 33 877
Jung‐woo Chae South Korea 15 126 0.8× 102 0.7× 58 0.5× 22 0.2× 201 2.1× 95 778
Ju‐Seop Kang South Korea 15 71 0.4× 56 0.4× 51 0.4× 24 0.2× 158 1.6× 48 602
Konrad E. Tomaszewski United States 11 92 0.6× 90 0.6× 43 0.4× 58 0.5× 225 2.3× 18 753
David B. Haughey United States 15 80 0.5× 120 0.9× 86 0.7× 17 0.2× 123 1.3× 34 611
Toshinobu Aoyama Japan 17 94 0.6× 79 0.6× 335 2.8× 115 1.1× 107 1.1× 81 837

Countries citing papers authored by Tetsuya Aiba

Since Specialization
Citations

This map shows the geographic impact of Tetsuya Aiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Aiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Aiba more than expected).

Fields of papers citing papers by Tetsuya Aiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Aiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Aiba. The network helps show where Tetsuya Aiba may publish in the future.

Co-authorship network of co-authors of Tetsuya Aiba

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Aiba. A scholar is included among the top collaborators of Tetsuya Aiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Aiba. Tetsuya Aiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toko, Haruhiro, et al.. (2025). An Underlying Mechanism for the Altered Hypoglycemic Effects of Nateglinide in Rats with Acute Peripheral Inflammation. Biological and Pharmaceutical Bulletin. 48(1). 51–59.
2.
3.
4.
Murakami, Yoshiki, et al.. (2011). Pharmacokinetic properties of newly synthesized retinoid X receptor agonists possessing a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic acid skeleton in rats. Drug Development and Industrial Pharmacy. 37(9). 1060–1067. 3 indexed citations
5.
Ishikawa, Atsuko, et al.. (2010). Altered electrolyte handling of the choroid plexus in rats with glycerol‐induced acute renal failure. Biopharmaceutics & Drug Disposition. 31(8-9). 455–463. 3 indexed citations
6.
Makita, Takashi, et al.. (2009). Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased. Biopharmaceutics & Drug Disposition. 30(1). 1–8. 2 indexed citations
7.
Aiba, Tetsuya, et al.. (2009). Comparative Study of Increased Plasma Quinidine Concentration in Rats with Glyceroland Cisplatin-induced Acute Renal Failure. Drug Metabolism and Pharmacokinetics. 24(5). 451–457. 25 indexed citations
8.
Tanaka, Akihiro, Tetsuya Aiba, Takashi Otsuka, et al.. (2009). Population Pharmacokinetic Analysis of Vancomycin Using Serum Cystatin C as a Marker of Renal Function. Antimicrobial Agents and Chemotherapy. 54(2). 778–782. 53 indexed citations
9.
Ishikawa, Atsuko, et al.. (2008). Decreased Lithium Disposition to Cerebrospinal Fluid in Rats with Glycerol-induced Acute Renal Failure. Pharmaceutical Research. 25(10). 2243–2249. 10 indexed citations
10.
Aiba, Tetsuya, et al.. (2007). Capsaicin-Induced Increase of Intestinal Cefazolin Absorption in Rats. Drug Metabolism and Pharmacokinetics. 22(6). 445–449. 7 indexed citations
11.
Aiba, Tetsuya, et al.. (2007). Alteration of Therapeutic Efficacy of Lipid Microspheres Incorporating Prostaglandin E1 by Mixing with Aqueous Solution. Journal of Pharmaceutical Sciences. 96(4). 935–943. 3 indexed citations
12.
Aiba, Tetsuya, et al.. (2006). Peritoneal Dialysis Alters Tolbutamide Pharmacokinetics in Rats with Experimental Acute Renal Failure. Drug Metabolism and Pharmacokinetics. 21(4). 291–296. 8 indexed citations
13.
Aiba, Tetsuya, et al.. (2005). The Effects of Culture Conditions on CYP3A4 and MDR1 mRNA Induction by 1α,25-Dihydroxyvitamin D3 in Human Intestinal Cell Lines, Caco-2 and LS180†. Drug Metabolism and Pharmacokinetics. 20(4). 268–274. 42 indexed citations
14.
15.
Aiba, Tetsuya, et al.. (1999). Effect of Dosage Form on Stereoisomeric Inversion of Ibuprofen in Volunteers.. Biological and Pharmaceutical Bulletin. 22(6). 616–622. 13 indexed citations
16.
Aiba, Tetsuya, et al.. (1994). Renal Handling of Tobramycin in the Isolated Perfused Rat Kidney. Journal of Pharmaceutical Sciences. 83(5). 723–726. 2 indexed citations
17.
Katayama, Kazunori, et al.. (1992). Effect of l-Menthol on the Permeation of Indomethacin, Mannitol and Cortisone through Excised Hairless Mouse Skin.. Chemical and Pharmaceutical Bulletin. 40(11). 3097–3099. 20 indexed citations
18.
Kamiya, Akira, Yusuke Tanigawara, Yoshihiro Saito, et al.. (1990). Moment Analysis of Drug Disposition in Kidney. II: Urine pH-Dependent Tubular Secretion of Tetraethylammonium in the Isolated Perfused Rat Kidney. Journal of Pharmaceutical Sciences. 79(8). 692–697. 11 indexed citations
19.
20.
Hori, Ryohei, Yusuke Tanigawara, Yoshihiro Saito, et al.. (1988). Moment analysis of drug disposition in kidney: Transcellular transport kinetics of p-Aminohippurate in the Isolated Perfused Rat Kidney. Journal of Pharmaceutical Sciences. 77(6). 471–476. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale K. Yu Breakdown of academic impact, for papers by Keith E. Anderson Breakdown of academic impact, for papers by Elena Suárez Breakdown of academic impact, for papers by M Ronchi Breakdown of academic impact, for papers by Jung‐woo Chae Breakdown of academic impact, for papers by Ju‐Seop Kang Breakdown of academic impact, for papers by Konrad E. Tomaszewski Breakdown of academic impact, for papers by David B. Haughey Breakdown of academic impact, for papers by Toshinobu Aoyama
Rankless by CCL
2026